Fig. 2
From: TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients
Relative gene expression of TRIM16 (Tripartite-motif-16) in breast cancer samples in comparison with normal breast tissues and evaluation of relative gene expression of TRIM16 in 2 different clinical and pathological parameters through Real-time PCR. A The expression of the TRIM16 gene was significantly decreased in breast cancer tissues. B Relative gene expression of TRIM3 was evaluated in different grades of breast cancer. C Relative expression of TRIM16 gene was compared between lymphatic/vascular invasive group and non-invasive group. D Relative expression of TRIM16 was compared between perineural invasive and non-invasive group. *p < 0.05, ***p < 0.001, ****p < 0.0001 significantly different from normal group. #p < 0.05 significantly different from the selected group